US2019135942A1PendingUtilityA1
Protein purification using bis-tris buffer
Est. expiryNov 23, 2031(~5.3 yrs left)· nominal 20-yr term from priority
C07K 16/18B01D 15/3809C07K 1/22C07K 16/12C07K 1/36C07K 16/40C07K 1/165
47
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention provides a two-step chromatography process for small and large-scale purification of proteins, specifically monoclonal antibodies, using only four buffer solutions made from a mother solution.
Claims
exact text as granted — not AI-modified1 . A method for purifying a protein from solution comprising:
(a) a first chromatography step comprising:
passing said solution over a first chromatography column;
eluting a crude protein eluent from the first chromatography column using a first elution buffer; and
(b) a second chromatography step comprising:
passing the crude protein eluent obtained at the end of step (a) over a second chromatography column;
recovering purified protein from the second chromatography column using a second elution buffer
wherein each of the buffers comprises Bis Tris.
2 . The method of claim 1 , wherein each one of the two chromatography steps comprises:
passing equilibration buffer over the chromatography column; passing the solution or the crude protein eluent over the chromatography column; passing equilibration buffer over the chromatography column; optionally passing wash and sanitation buffer over the chromatography column; optionally passing equilibration buffer over the chromatography column; eluting the crude protein eluent or recovering purified protein from the chromatography column using an elution buffer,
wherein each of the buffers comprises Bis Tris.
3 . (canceled)
4 . The method of claim 1 , wherein each of the buffers consists of Bis Tris, acetic acid, NaCl, and water.
5 . The method of claim 1 , wherein the method for purifying a protein from solution only comprises two chromatographic steps.
6 . The method of claim 1 , wherein one of the chromatography columns is an affinity chromatography column.
7 . The method of claim 1 , wherein said affinity chromatography column is a Protein A column.
8 . The method of claim 1 , wherein one of the chromatography columns is a multi-modal resin chromatography column.
9 - 11 . (canceled)
12 . The method of claim 1 , wherein said method comprises the steps of:
(a) a first chromatography step comprising:
(i) passing equilibration buffer over a first chromatography column;
(ii) passing the solution over the first chromatography column;
(iii) passing equilibration buffer over the first chromatography column;
(iv) passing wash and sanitation buffer over the first chromatography column;
(v) passing equilibration buffer over the first chromatography column;
(vi) eluting a crude protein eluent from the first chromatography column using a first elution buffer; and
(vii) optionally adjusting the pH of the crude protein eluent using a Bis Tris solution; and
(b) a second chromatography step comprising:
(i) passing equilibration buffer over a second chromatography column;
(ii) passing the crude protein eluent from step (a) over the second chromatography column;
(iii) passing equilibration buffer over the second chromatography column; and
(iv) recovering purified protein from the second chromatography column using a second elution buffer.
13 - 15 . (canceled)
16 . The method of claim 1 , wherein said method comprises the steps of:
(a) a first chromatography step comprising:
(i) passing equilibration buffer over a first chromatography column;
(ii) passing the solution over the first chromatography column;
(iii) passing equilibration buffer over the first chromatography column;
(iv) eluting a crude protein eluent from the first chromatography column using a first elution buffer; and
(v) optionally adjusting the pH of the crude protein eluent using a Bis Tris solution; and
(b) a second chromatography step comprising:
(i) passing equilibration buffer over a second chromatography column;
(ii) passing the crude protein eluent from step (a) over the second chromatography column;
(iii) passing equilibration buffer over the second chromatography column;
(iv) passing wash and sanitation buffer over the second chromatography column;
(v) passing equilibration buffer over the second chromatography column; and
(vi) recovering purified protein from the second chromatography column using a second elution buffer.
17 - 20 . (canceled)
21 . The method of claim 16 , wherein the protein is a monoclonal antibody.
22 . (canceled)
23 . The method of claim 16 , further comprising, after step (b), a step (c) of passing the crude protein eluent over a membrane adsorber.
24 . The method of claim 23 , wherein said membrane adsorber is a salt tolerant interaction chromatography membrane adsorber.
25 . The method of claim 16 , further comprising a nanofiltration step after step (b) or (c).
26 . The method of claim 25 , further comprising an ultrafiltration and diafiltration step after the nanofiltration step.
27 . The method of claim 16 , wherein the first elution buffer comprises 15 to 25 mM Bis Tris, and 15 to 25 mM NaCl, adjusted to a pH comprised between 3 and 4 with acetic acid.
28 - 34 . (canceled)
35 . The method of claim 1 , wherein the purified protein is recovered with a yield of at least 85%.
36 . (canceled)
37 . The method of claim 1 , further comprising the step of formulating the recovered purified protein into a pharmaceutical composition.
38 - 43 . (canceled)Join the waitlist — get patent alerts
Track US2019135942A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.